Although Mel enhances B7 expression on tumor cells, which leads to engagement of tumor reactive T cells, it has been known for some time that MM cells can also express CD28 and that the level of expression correlates with disease progression and poor prognosis [23]. This evidence concerns the gene CD80 and Miyoshi myopathy.